Apoptotic process in cystic fibrosis cells

Area of Science:

• Cell Biology
• Genetics
• Immunology

Background:

• Cystic fibrosis (CF) is an inherited disorder caused by mutations in the CF transmembrane conductance regulator (CFTR) gene.
• CF pathology involves exaggerated inflammation, tissue damage, and bacterial colonization, particularly in the respiratory tract.
• Apoptosis dysfunction is a debated but significant factor in CF pathogenesis.

Purpose of the Study:

• To explore the role of apoptotic dysfunction in cystic fibrosis.
• To understand how apoptosis contributes to the inflammatory cycle in CF.
• To review current therapeutic strategies targeting CFTR.

Main Methods:

• Review of existing literature on apoptosis and CF.
• Analysis of cellular mechanisms underlying CF-related inflammation and apoptosis.
• Examination of efferocytosis defects in CF.

Main Results:

• Apoptosis dysfunction, with increased susceptibility in epithelial cells and impaired clearance, contributes to CF inflammation.
• Retention of mutated CFTR in the endoplasmic reticulum can trigger inflammation and apoptosis.
• Defective efferocytosis leads to the accumulation of apoptotic cells, exacerbating inflammation in CF patients.

Conclusions:

• Apoptosis plays a complex role in cystic fibrosis, impacting epithelial cells and neutrophils.
• Impaired clearance of apoptotic cells is a key factor in the persistent inflammation seen in CF.
• Current research focuses on CFTR-targeted therapies, including pharmacotherapy, cell, and gene therapy, to address the disease.